🇺🇸 YTTRIUM Y 90 IBRITUMOMAB TIUXETAN in United States

YTTRIUM Y 90 IBRITUMOMAB TIUXETAN (YTTRIUM Y 90 IBRITUMOMAB TIUXETAN) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

YTTRIUM Y 90 IBRITUMOMAB TIUXETAN in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is YTTRIUM Y 90 IBRITUMOMAB TIUXETAN approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for YTTRIUM Y 90 IBRITUMOMAB TIUXETAN in United States?

Marketing authorisation holder not available in our data.